{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T17:27:08Z","timestamp":1786814828195,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["Materials Systems Engineering (MSE)"],"award-info":[{"award-number":["Materials Systems Engineering (MSE)"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["Materials Systems Engineering (MSE)"],"award-info":[{"award-number":["Materials Systems Engineering (MSE)"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["Materials Systems Engineering (MSE)"],"award-info":[{"award-number":["Materials Systems Engineering (MSE)"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["Materials Systems Engineering (MSE)"],"award-info":[{"award-number":["Materials Systems Engineering (MSE)"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["Materials Systems Engineering (MSE)"],"award-info":[{"award-number":["Materials Systems Engineering (MSE)"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["Materials Systems Engineering (MSE)"],"award-info":[{"award-number":["Materials Systems Engineering (MSE)"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["Materials Systems Engineering (MSE)"],"award-info":[{"award-number":["Materials Systems Engineering (MSE)"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["Materials Systems Engineering (MSE)"],"award-info":[{"award-number":["Materials Systems Engineering (MSE)"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["OR124\/24-1"],"award-info":[{"award-number":["OR124\/24-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["EkoEstMed\u2013FKZ 01ZZ2015"],"award-info":[{"award-number":["EkoEstMed\u2013FKZ 01ZZ2015"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pancreatic tumors are characterized by a prominent desmoplastic stroma that can account for up to 90% of the tumor. Given the marked upregulation of CD44, a family of transmembrane glycoproteins, in pancreatic cancer-associated fibroblasts (CAFs), we investigated its role in regulating myofibroblastic and inflammatory CAF phenotypes. Conditional deletion of\n                    <jats:italic>Cd44<\/jats:italic>\n                    in fibroblastic cells in\n                    <jats:italic>Cd44<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>fl\/fl<\/jats:italic>\n                    <\/jats:sup>\n                    <jats:italic>;Pdgfr\u03b2CreER<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>T2<\/jats:italic>\n                    <\/jats:sup>\n                    mice significantly reduced tumor growth and was associated with a significant reduction in intratumoral regulatory T cells (T\n                    <jats:sub>reg<\/jats:sub>\n                    ). Consistently, in human CAFs CRISPR\/Cas9-edited to delete\n                    <jats:italic>CD44<\/jats:italic>\n                    , the fibroblasts\u2019 morphology changed drastically: CAFs lost their elongated phenotype and adopted a round shape, reflecting their inactivation. This was accompanied by a significant downregulation of activation markers, unresponsiveness to exogenous stimuli, and reduced contractile activity. Furthermore, CD44 ablation decreased extracellular matrix production and altered the immunomodulatory cytokine secretion, highlighting its role in both fibrosis and immune regulation. Finally, CD44-deficient CAFs exhibited a reduced capacity to suppress anti-tumor immune responses by failing to induce immunosuppressive programs in dendritic cells (DCs) and by increasing cytotoxic T cell (CTL)-mediated tumor cell killing. Collectively, we identify CD44 as a regulator of CAF activation and immunosuppressive function, linking stromal remodeling to immune evasion in pancreatic cancer and supporting CD44 as a potential therapeutic strategy to reprogram the tumor stroma and enhance anti-tumor immunity.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09155-5","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:03:22Z","timestamp":1786806202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Loss of CD44 re-educates pancreatic cancer-associated fibroblasts modulating their fibrotic and immunosuppressive functions"],"prefix":"10.1038","volume":"17","author":[{"given":"Sven M\u00e1t\u00e9","family":"Treffert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9273-5427","authenticated-orcid":false,"given":"Yvonne Madeleine","family":"Heneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Launhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Akilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Stanganello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-9481","authenticated-orcid":false,"given":"Geoffroy","family":"Andrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Hoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen Joachim","family":"Sonnentag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa-Marie","family":"Mehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonel","family":"Munoz-Sagredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2939-9257","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Orian-Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"key":"9155_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O\u2019Reilly EM, et al. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:987\u20131002.","journal-title":"Ann Oncol"},{"key":"9155_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820962117","volume":"19","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020;19:1533033820962117.","journal-title":"Technol Cancer Res Treat"},{"key":"9155_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.612271","volume":"12","author":"S Liot","year":"2021","unstructured":"Liot S, Balas J, Aubert A, Prigent L, Mercier-Gouy P, Verrier B, et al. Stroma involvement in pancreatic ductal adenocarcinoma: an overview focusing on extracellular matrix proteins. Front Immunol. 2021;12:612271.","journal-title":"Front Immunol"},{"key":"9155_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1158\/2159-8290.CD-21-0601","volume":"12","author":"EJ Helms","year":"2022","unstructured":"Helms EJ, Berry MW, Chaw RC, DuFort CC, Sun D, Onate MK, et al. Mesenchymal lineage heterogeneity underlies nonredundant functions of pancreatic cancer\u2013associated fibroblasts. Cancer Discov. 2022;12:484\u2013501.","journal-title":"Cancer Discov"},{"key":"9155_CR5","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1158\/2159-8290.CD-25-1337","volume":"16","author":"J Nigri","year":"2026","unstructured":"Nigri J, Lan W, Fung ML, Kayser C, Desch\u00eanes A, Hinds J, et al. Myofibroblasts induce neuroplasticity to promote pancreatic inflammation and cancer progression. Cancer Discov. 2026;16:1014\u201334.","journal-title":"Cancer Discov"},{"key":"9155_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccr.2011.01.020","volume":"19","author":"M Quante","year":"2011","unstructured":"Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S, et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011;19:257\u201372.","journal-title":"Cancer Cell"},{"key":"9155_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"9155_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-physiol-020518-114515","volume":"81","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Crawford HC, Pasca di Magliano M. Epithelial-stromal interactions in pancreatic cancer. Annu Rev Physiol. 2019;81:211\u201333.","journal-title":"Annu Rev Physiol"},{"key":"9155_CR9","doi-asserted-by":"publisher","first-page":"e129212.","DOI":"10.1172\/jci.insight.129212","volume":"4","author":"AN Hosein","year":"2019","unstructured":"Hosein AN, Huang H, Wang Z, Parmar K, Du W, Huang J, et al. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. JCI Insight. 2019;4:e129212.","journal-title":"JCI Insight"},{"key":"9155_CR10","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9:1102\u201323.","journal-title":"Cancer Discov"},{"key":"9155_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, et al. IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 2019;9:282\u2013301.","journal-title":"Cancer Discov"},{"key":"9155_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","volume":"80","author":"S Das","year":"2020","unstructured":"Das S, Shapiro B, Vucic EA, Vogt S, Bar-Sagi D. Tumor cell\u2013derived IL1\u03b2 promotes desmoplasia and immune suppression in pancreatic cancer. Cancer Res. 2020;80:1088\u2013101.","journal-title":"Cancer Res"},{"key":"9155_CR13","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1158\/0008-5472.CAN-12-4601","volume":"73","author":"TA Mace","year":"2013","unstructured":"Mace TA, Ameen Z, Collins A, Wojcik S, Mair M, Young GS, et al. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. Cancer Res. 2013;73:3007\u201318.","journal-title":"Cancer Res"},{"key":"9155_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.7","volume":"5","author":"JT Cheng","year":"2016","unstructured":"Cheng JT, Deng YN, Yi HM, Wang GY, Fu BS, Chen WJ, et al. Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation. Oncogenesis. 2016;5:e198.","journal-title":"Oncogenesis"},{"key":"9155_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fimmu.2019.00847","volume":"10","author":"L Gorchs","year":"2019","unstructured":"Gorchs L, Fern\u00e1ndez Moro C, Bankhead P, Kern KP, Sadeak I, Meng Q, et al. Human pancreatic carcinoma-associated fibroblasts promote expression of co-inhibitory markers on CD4(+) and CD8(+) T-cells. Front Immunol. 2019;10:847.","journal-title":"Front Immunol"},{"key":"9155_CR16","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-0205","volume":"24","author":"T Kato","year":"2018","unstructured":"Kato T, Noma K, Ohara T, Kashima H, Katsura Y, Sato H, et al. Cancer-associated fibroblasts affect intratumoral CD8(+) and FoxP3(+) T cells Via IL6 in the tumor microenvironment. Clin Cancer Res. 2018;24:4820\u201333.","journal-title":"Clin Cancer Res"},{"key":"9155_CR17","doi-asserted-by":"publisher","first-page":"613815","DOI":"10.3389\/fimmu.2020.613815","volume":"11","author":"ZC Schmiechen","year":"2020","unstructured":"Schmiechen ZC, Stromnes IM. Mechanisms governing immunotherapy resistance in pancreatic ductal adenocarcinoma. Front Immunol. 2020;11:613815.","journal-title":"Front Immunol"},{"key":"9155_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC \u00d6zdemir","year":"2014","unstructured":"\u00d6zdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu C-C, Simpson TR, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25:719\u201334.","journal-title":"Cancer Cell"},{"key":"9155_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25:735\u201347.","journal-title":"Cancer Cell"},{"key":"9155_CR20","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","volume":"12","author":"KM McAndrews","year":"2022","unstructured":"McAndrews KM, Chen Y, Darpolor JK, Zheng X, Yang S, Carstens JL, et al. Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer. Cancer Discov. 2022;12:1580\u201397.","journal-title":"Cancer Discov"},{"key":"9155_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1152312","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Zhou J, Wang X, Li C, Ma Z, Wan Q, et al. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment. Front Immunol. 2023;14:1152312.","journal-title":"Front Immunol"},{"key":"9155_CR22","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1182\/blood-2009-04-219204","volume":"114","author":"M Tremmel","year":"2009","unstructured":"Tremmel M, Matzke A, Albrecht I, Laib AM, Olaku V, Ballmer-Hofer K, et al. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. Blood. 2009;114:5236\u201344.","journal-title":"Blood"},{"key":"9155_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.gastro.2015.10.020","volume":"150","author":"A Matzke-Ogi","year":"2016","unstructured":"Matzke-Ogi A, Jannasch K, Shatirishvili M, Fuchs B, Chiblak S, Morton J, et al. Inhibition of tumor growth and metastasis in pancreatic cancer models by interference with CD44v6 signaling. Gastroenterology. 2016;150:513\u201325.e10.","journal-title":"Gastroenterology"},{"key":"9155_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng J, Sun BF, Chen CY, Zhou JY, Chen YS, Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29:725\u201338.","journal-title":"Cell Res"},{"key":"9155_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.342","volume":"7","author":"M Shatirishvili","year":"2016","unstructured":"Shatirishvili M, Burk AS, Franz CM, Pace G, Kastilan T, Breuhahn K, et al. Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress. Cell Death Dis. 2016;7:e2461.","journal-title":"Cell Death Dis"},{"key":"9155_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10456-017-9570-9","volume":"20","author":"H Cuervo","year":"2017","unstructured":"Cuervo H, Pereira B, Nadeem T, Lin M, Lee F, Kitajewski J, et al. PDGFR\u03b2-P2A-CreER(T2) mice: a genetic tool to target pericytes in angiogenesis. Angiogenesis. 2017;20:655\u201362.","journal-title":"Angiogenesis"},{"key":"9155_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1159\/000320540","volume":"10","author":"A Mathison","year":"2010","unstructured":"Mathison A, Liebl A, Bharucha J, Mukhopadhyay D, Lomberk G, Shah V, et al. Pancreatic stellate cell models for transcriptional studies of desmoplasia-associated genes. Pancreatology. 2010;10:505\u201316.","journal-title":"Pancreatology"},{"key":"9155_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1042\/BST20160387","volume":"45","author":"B Erdogan","year":"2017","unstructured":"Erdogan B, Webb DJ. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochem Soc Trans. 2017;45:229\u201336.","journal-title":"Biochem Soc Trans"},{"key":"9155_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ceb.2018.09.002","volume":"56","author":"J Barbaz\u00e1n","year":"2019","unstructured":"Barbaz\u00e1n J, Matic Vignjevic D. Cancer associated fibroblasts: is the force the path to the dark side? Curr Opin Cell Biol. 2019;56:71\u20139.","journal-title":"Curr Opin Cell Biol"},{"key":"9155_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3892\/ijo.2015.3282","volume":"48","author":"L Tian","year":"2016","unstructured":"Tian L, Lu ZP, Cai BB, Zhao LT, Qian D, Xu QC, et al. Activation of pancreatic stellate cells involves an EMT-like process. Int J Oncol. 2016;48:783\u201392.","journal-title":"Int J Oncol"},{"key":"9155_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep13402","volume":"5","author":"J Maier","year":"2015","unstructured":"Maier J, Traenkle B, Rothbauer U. Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodies. Sci Rep. 2015;5:13402.","journal-title":"Sci Rep"},{"key":"9155_CR32","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/nprot.2017.107","volume":"12","author":"R Kaukonen","year":"2017","unstructured":"Kaukonen R, Jacquemet G, Hamidi H, Ivaska J. Cell-derived matrices for studying cell proliferation and directional migration in a complex 3D microenvironment. Nat Protoc. 2017;12:2376\u201390.","journal-title":"Nat Protoc"},{"key":"9155_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0085-z","volume":"7","author":"A Herrera","year":"2018","unstructured":"Herrera A, Herrera M, Guerra-Perez N, Galindo-Pumari\u00f1o C, Larriba MJ, Garc\u00eda-Barber\u00e1n V, et al. Endothelial cell activation on 3D-matrices derived from PDGF-BB-stimulated fibroblasts is mediated by Snail1. Oncogenesis. 2018;7:76.","journal-title":"Oncogenesis"},{"key":"9155_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","volume":"21","author":"PP Provenzano","year":"2012","unstructured":"Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21:418\u201329.","journal-title":"Cancer Cell"},{"key":"9155_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-4-38","volume":"4","author":"PP Provenzano","year":"2006","unstructured":"Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4:38.","journal-title":"BMC Med"},{"key":"9155_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao4881","volume":"4","author":"P Kollmannsberger","year":"2018","unstructured":"Kollmannsberger P, Bidan CM, Dunlop JWC, Fratzl P, Vogel V. Tensile forces drive a reversible fibroblast-to-myofibroblast transition during tissue growth in engineered clefts. Sci Adv. 2018;4:eaao4881.","journal-title":"Sci Adv"},{"key":"9155_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1165\/rcmb.2012-0050OC","volume":"47","author":"X Huang","year":"2012","unstructured":"Huang X, Yang N, Fiore VF, Barker TH, Sun Y, Morris SW, et al. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol. 2012;47:340\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9155_CR38","doi-asserted-by":"publisher","first-page":"2995.","DOI":"10.3390\/cancers13122995","volume":"13","author":"L Gorchs","year":"2021","unstructured":"Gorchs L, Kaipe H. Interactions between cancer-associated fibroblasts and T cells in the pancreatic tumor microenvironment and the role of chemokines. Cancers (Basel). 2021;13:2995.","journal-title":"Cancers (Basel)"},{"key":"9155_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"9155_CR40","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","volume":"324","author":"KP Olive","year":"2009","unstructured":"Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324:1457\u201361.","journal-title":"Science"},{"key":"9155_CR41","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1158\/0008-5472.CAN-23-3252","volume":"85","author":"J Cumming","year":"2025","unstructured":"Cumming J, Maneshi P, Dongre M, Alsaed T, Dehghan-Nayeri MJ, Ling A, et al. Dissecting FAP+ cell diversity in pancreatic cancer uncovers an interferon-response subtype of cancer-associated fibroblasts with tumor-restraining properties. Cancer Res. 2025;85:2388\u2013411.","journal-title":"Cancer Res"},{"key":"9155_CR42","doi-asserted-by":"publisher","first-page":"61.","DOI":"10.3390\/cancers15010061","volume":"15:","author":"R Peiffer","year":"2022","unstructured":"Peiffer R, Boumahd Y, Gullo C, Crake R, Letellier E, Bellahc\u00e8ne A. Cancer-associated fibroblast diversity shapes tumor metabolism in pancreatic cancer. Cancers (Basel). 2022;15:61.","journal-title":"Cancers (Basel)"},{"key":"9155_CR43","doi-asserted-by":"publisher","first-page":"39703","DOI":"10.1074\/jbc.M204320200","volume":"277","author":"LY Bourguignon","year":"2002","unstructured":"Bourguignon LY, Singleton PA, Zhu H, Zhou B. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem. 2002;277:39703\u201312.","journal-title":"J Biol Chem"},{"key":"9155_CR44","doi-asserted-by":"publisher","first-page":"G110","DOI":"10.1152\/ajpgi.00412.2010","volume":"301","author":"AL Olsen","year":"2011","unstructured":"Olsen AL, Bloomer SA, Chan EP, Ga\u00e7a MD, Georges PC, Sackey B, et al. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol. 2011;301:G110\u20138.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9155_CR45","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ncb2756","volume":"15","author":"F Calvo","year":"2013","unstructured":"Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry SI, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15:637\u201346.","journal-title":"Nat Cell Biol"},{"key":"9155_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474:179\u201383.","journal-title":"Nature"},{"key":"9155_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm.4082","volume":"22","author":"H Laklai","year":"2016","unstructured":"Laklai H, Miroshnikova YA, Pickup MW, Collisson EA, Kim GE, Barrett AS, et al. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med. 2016;22:497\u2013505.","journal-title":"Nat Med"},{"key":"9155_CR48","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.cellsig.2014.07.031","volume":"26","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Xia H, Ge X, Chen Q, Yuan D, Chen Q, et al. CD44 acts through RhoA to regulate YAP signaling. Cell Signal. 2014;26:2504\u201313.","journal-title":"Cell Signal"},{"key":"9155_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-245","volume":"11","author":"H-O Lee","year":"2011","unstructured":"Lee H-O, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer. 2011;11:245.","journal-title":"BMC Cancer"},{"key":"9155_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10330-y","volume":"22","author":"T Luong","year":"2022","unstructured":"Luong T, Cukierman E. Eribulin normalizes pancreatic cancer-associated fibroblasts by simulating selected features of TGF\u03b2 inhibition. BMC Cancer. 2022;22:1255.","journal-title":"BMC Cancer"},{"key":"9155_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82937-3","volume":"11","author":"JI Alexander","year":"2021","unstructured":"Alexander JI, Vendramini-Costa DB, Francescone R, Luong T, Franco-Barraza J, Shah N, et al. Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma. Sci Rep. 2021;11:3802.","journal-title":"Sci Rep"},{"key":"9155_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.gene.2011.11.064","volume":"494","author":"GM Campo","year":"2012","unstructured":"Campo GM, Avenoso A, D\u2019Ascola A, Scuruchi M, Prestipino V, Calatroni A, et al. Hyaluronan in part mediates IL-1beta-induced inflammation in mouse chondrocytes by up-regulating CD44 receptors. Gene. 2012;494:24\u201335.","journal-title":"Gene"},{"key":"9155_CR53","doi-asserted-by":"publisher","first-page":"237ra67","DOI":"10.1126\/scitranslmed.3007974","volume":"6","author":"SL Highfill","year":"2014","unstructured":"Highfill SL, Cui Y, Giles AJ, Smith JP, Zhang H, Morse E, et al. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Sci Transl Med. 2014;6:237ra67.","journal-title":"Sci Transl Med"},{"key":"9155_CR54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","volume":"8","author":"DA Thomas","year":"2005","unstructured":"Thomas DA, Massagu\u00e9 J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell. 2005;8:369\u201380.","journal-title":"Cancer Cell"},{"key":"9155_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5305306","volume":"2020","author":"A Samiea","year":"2020","unstructured":"Samiea A, Yoon JSJ, Ong CJ, Zoubeidi A, Chamberlain TC, Mui AL. Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells. Prostate Cancer. 2020;2020:5305306.","journal-title":"Prostate Cancer"},{"key":"9155_CR56","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","volume":"30","author":"EM Shevach","year":"2009","unstructured":"Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009;30:636\u201345.","journal-title":"Immunity"},{"key":"9155_CR57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.canlet.2019.01.013","volume":"446","author":"H Cheng","year":"2019","unstructured":"Cheng H, Fan K, Luo G, Fan Z, Yang C, Huang Q, et al. Kras(G12D) mutation contributes to regulatory T cell conversion through activation of the MEK\/ERK pathway in pancreatic cancer. Cancer Lett. 2019;446:103\u201311.","journal-title":"Cancer Lett"},{"key":"9155_CR58","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.4049\/jimmunol.0900986","volume":"183","author":"B Baban","year":"2009","unstructured":"Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, Munn DH, et al. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol. 2009;183:2475\u201383.","journal-title":"J Immunol"},{"key":"9155_CR59","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","volume":"44","author":"TW Stone","year":"2023","unstructured":"Stone TW, Williams RO. Modulation of T cells by tryptophan metabolites in the kynurenine pathway. Trends Pharm Sci. 2023;44:442\u201356.","journal-title":"Trends Pharm Sci"},{"key":"9155_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49282-1","volume":"15","author":"A Varveri","year":"2024","unstructured":"Varveri A, Papadopoulou M, Papadovasilakis Z, Compeer EB, Legaki AI, Delis A, et al. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development. Nat Commun. 2024;15:4988.","journal-title":"Nat Commun"},{"key":"9155_CR61","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3440","volume":"9","author":"S Waise","year":"2019","unstructured":"Waise S, Parker R, Rose-Zerilli MJJ, Layfield DM, Wood O, West J, et al. An optimized method to isolate human fibroblasts from tissue for ex vivo analysis. Bio Protoc. 2019;9:e3440.","journal-title":"Bio Protoc"},{"key":"9155_CR62","volume":"3","author":"JL Chitty","year":"2020","unstructured":"Chitty JL, Skhinas JN, Filipe EC, Wang S, Cupello CR, Grant RD, et al. The Mini-Organo: a rapid high-throughput 3D coculture organotypic assay for oncology screening and drug development. Cancer Rep. 2020;3:e1209.","journal-title":"Cancer Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09155-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09155-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09155-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T17:01:28Z","timestamp":1786813288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09155-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9155"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09155-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Human patient-derived samples used in the single cell RNA sequencing were obtained from previously published datasets (Genome Sequence Archive: CRA001160; derived from the study of Peng et al. [\n                      \n                      ]) and were collected under the original ethical approvals and informed consent procedures described in the corresponding publications. No additional patient recruitment, intervention, or collection of human samples was performed in the present study. Therefore, no new ethical approval was required for the analysis of these previously published data.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"729"}}